Research
US FDA approves new Alzheimer’s drug
August 4, 2021
A tortuous history and uncertain benefits have led to controversy over its approval. The US Food and Drug Administration (FDA) has granted conditional approval to a new drug, aducanumab (marketed as Aduhelm) for the treatment of Alzheimer’s disease. Aducanumab is a monoclonal antibody that reduces the amount of beta-amyloid in the brain. Beta-amyloid is a…
Today
Research
US FDA approves new Alzheimer’s drug
August 4, 2021
A tortuous history and uncertain benefits have led to controversy over its approval. The US…
Research
80% of Australian Muslims have experienced discriminati...
August 4, 2021
An Australian Human Rights Commission survey has found damning evidence of discrimination against Muslims in…
Research
Female nurses twice as likely to commit suicide: study...
July 15, 2021
A University of Michigan study has indicated that suicide rates among female nurses were roughly double…
Research
Reliance on temporary staff associated with increased p...
June 24, 2021
A study has found that heavy reliance on temporary nursing staff in medical and surgical…
Research
Safe staffing saves lives in craniotomy patients
June 24, 2021
A study of data from Korea’s National Health Insurance Service has found that in-hospital mortality…
Research
At last, health, aged care and quarantine workers get t...
June 21, 2021
Almost a year ago, in July 2020, our calls for the government to urgently upgrade…
Research
LGBT+ employees in religiously affiliated workplaces
June 15, 2021
Do you identify as LGBTQ+? Is your workplace religiously affiliated? We would like to hear…
Research
Queensland’s ratios save lives and money
June 1, 2021
New research published in The Lancet shows the Queensland public health system has benefited greatly…
Research
Climate change to drive a third of doctors out of the N...
June 1, 2021
New research published in The Lancet Planetary Health found 34 per cent of doctors have…